• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于大体积直接进样超高效液相色谱-串联质谱法的三七提取物与三七总皂苷单药及联合用药的比较药代动力学研究

Large Volume Direct Injection Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Comparative Pharmacokinetic Study between Single and Combinatory Uses of Extract and Notoginseng Total Saponins.

作者信息

Chen Jinfeng, Guo Xiaoyu, Lu Yingyuan, Shi Mengling, Mu Haidong, Qian Yi, Wang Jinlong, Lu Mengqiu, Zhao Mingbo, Tu Pengfei, Song Yuelin, Jiang Yong

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

出版信息

Pharmaceutics. 2020 Feb 20;12(2):180. doi: 10.3390/pharmaceutics12020180.

DOI:10.3390/pharmaceutics12020180
PMID:32093170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7076352/
Abstract

The combination of extract (CTE) and notoginseng total saponins (NGTS), namely, CNP, presents a synergistic effect on myocardial ischemia protection. Herein, comparative pharmacokinetic studies between CNP and CTE/NGTS were conducted to clarify their synergistic mechanisms. A large volume direct injection ultra-high performance liquid chromatography-tandem mass spectrometry (LVDI-UHPLC-MS/MS) platform was developed for sensitively assaying the multi-component pharmacokinetic and in vitro cocktail assay of cytochrome p450 (CYP450) before and after compatibility of CTE and NGTS. The pharmacokinetic profiles of six predominantly efficacious components of CNP, including hydroxysafflor yellow A (HSYA); ginsenosides Rg (GRg), Re (GRe), Rb (GRb), and Rd (GRd); and notoginsenoside R (NGR), were obtained, and the results disclosed that CNP could increase the exposure levels of HSYA, GRg, GRe, GRb, and NGR at varying degrees. The in vitro cocktail assay demonstrated that CNP exhibited more potent inhibition on CYP1A2 than CTE and NGTS, and GRg, GRb, GRd, quercetin, kaempferol, and 6-hydroxykaempferol were found to be the major inhibitory compounds. The developed pharmacokinetic interaction-based strategy provides a viable orientation for the compatibility investigation of herb medicines.

摘要

提取物(CTE)与人参总皂苷(NGTS)的组合,即CNP,对心肌缺血保护具有协同作用。在此,进行了CNP与CTE/NGTS之间的比较药代动力学研究,以阐明其协同机制。开发了一种大容量直接进样超高效液相色谱-串联质谱(LVDI-UHPLC-MS/MS)平台,用于灵敏地测定CTE与NGTS配伍前后的多组分药代动力学以及细胞色素P450(CYP450)的体外鸡尾酒试验。获得了CNP六种主要有效成分的药代动力学特征,包括羟基红花黄色素A(HSYA)、人参皂苷Rg(GRg)、Re(GRe)、Rb(GRb)和Rd(GRd)以及三七皂苷R1(NGR),结果表明CNP可不同程度地提高HSYA、GRg、GRe、GRb和NGR的暴露水平。体外鸡尾酒试验表明,CNP对CYP1A2的抑制作用比CTE和NGTS更强,并且发现GRg、GRb、GRd、槲皮素、山奈酚和6-羟基山奈酚是主要的抑制化合物。所开发的基于药代动力学相互作用的策略为草药配伍研究提供了一个可行的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/9d62609cb54a/pharmaceutics-12-00180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/b0af30506858/pharmaceutics-12-00180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/e23f38ce7af0/pharmaceutics-12-00180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/a6f2f66b761c/pharmaceutics-12-00180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/f5ec5bfbf20b/pharmaceutics-12-00180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/9d62609cb54a/pharmaceutics-12-00180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/b0af30506858/pharmaceutics-12-00180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/e23f38ce7af0/pharmaceutics-12-00180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/a6f2f66b761c/pharmaceutics-12-00180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/f5ec5bfbf20b/pharmaceutics-12-00180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c7/7076352/9d62609cb54a/pharmaceutics-12-00180-g005.jpg

相似文献

1
Large Volume Direct Injection Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Comparative Pharmacokinetic Study between Single and Combinatory Uses of Extract and Notoginseng Total Saponins.基于大体积直接进样超高效液相色谱-串联质谱法的三七提取物与三七总皂苷单药及联合用药的比较药代动力学研究
Pharmaceutics. 2020 Feb 20;12(2):180. doi: 10.3390/pharmaceutics12020180.
2
Comparative study on metabolic profiling and excretion in rat bile between combination of notoginseng total saponins and safflower total flavonoids and its individual extracts by LC-MS/MS.采用 LC-MS/MS 法比较研究三七总皂苷与红花总黄酮及其单体提取物在大鼠胆汁中的代谢谱和排泄情况。
J Pharm Biomed Anal. 2020 Jan 30;178:112936. doi: 10.1016/j.jpba.2019.112936. Epub 2019 Oct 16.
3
Comparative pharmacokinetic analysis of raw and steamed roots in rats by UPLC-MS/MS for simultaneously quantifying seven saponins.采用 UPLC-MS/MS 同时定量测定 7 种皂苷的大鼠生晒和蒸制根的比较药代动力学分析。
Pharm Biol. 2021 Dec;59(1):653-661. doi: 10.1080/13880209.2021.1928239.
4
Effects of Borneol on Pharmacokinetics and Tissue Distribution of Notoginsenoside R1 and Ginsenosides Rg1 and Re in Panax notoginseng in Rabbits.龙脑对三七中人参皂苷 R1、人参皂苷 Rg1 和 Re 药代动力学和组织分布的影响。
J Anal Methods Chem. 2013;2013:706723. doi: 10.1155/2013/706723. Epub 2013 Mar 31.
5
Brain distribution pharmacokinetics and integrated pharmacokinetics of Panax Notoginsenoside R1, Ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal administration of Panax Notoginseng Saponins assessed by UPLC/MS/MS.采用超高效液相色谱-串联质谱法(UPLC/MS/MS)评估三七总皂苷鼻腔给药后,三七皂苷R1、人参皂苷Rg1、Rb1、Re和Rd在大鼠体内的脑分布药代动力学及整合药代动力学。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15;969:264-71. doi: 10.1016/j.jchromb.2014.08.034. Epub 2014 Sep 3.
6
Effect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in Fufang Xueshuantong Capsule.配伍中药对复方血栓通胶囊中三七有效成分药代动力学的影响。
J Zhejiang Univ Sci B. 2017;18(4):343-352. doi: 10.1631/jzus.B1600235.
7
Evaluation of the effects of notoginseng total saponins (NS), safflower total flavonoids (SF), and the combination of NS and SF (CNS) on the activities of cytochrome P450 enzymes using a cocktail method in rats.采用鸡尾酒法评价三七总皂苷(NS)、红花总黄酮(SF)以及三七总皂苷与红花总黄酮联合用药(CNS)对大鼠细胞色素P450酶活性的影响。
Biomed Chromatogr. 2021 Oct;35(10):e5171. doi: 10.1002/bmc.5171. Epub 2021 May 31.
8
Development and validation of an UFLC-MS/MS assay for the absolute quantitation of nine notoginsenosides in rat plasma: Application to the pharmacokinetic study of Panax Notoginseng Extract.大鼠血浆中九种三七皂苷的超高效液相色谱-串联质谱绝对定量分析方法的建立与验证:应用于三七提取物的药代动力学研究
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jul 15;995-996:46-53. doi: 10.1016/j.jchromb.2015.05.022. Epub 2015 May 19.
9
Simultaneous determination of three saponins in human plasma after oral administration of compound danshen dripping pills by LC-MS/MS and its application in a pharmacokinetic study.LC-MS/MS 法同时测定人血浆中复方丹参滴丸口服后的 3 种皂苷及其在药代动力学研究中的应用。
J Pharm Biomed Anal. 2019 May 30;169:254-259. doi: 10.1016/j.jpba.2019.03.008. Epub 2019 Mar 5.
10
Effects of notoginsenoside R1 on CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 activities in rats by cocktail probe drugs.三七皂苷R1对大鼠CYP1A2、CYP2C11、CYP2D1和CYP3A1/2活性的鸡尾酒探针药物效应。
Pharm Biol. 2016;54(2):231-6. doi: 10.3109/13880209.2015.1029051. Epub 2015 Apr 2.

引用本文的文献

1
A Novel System for Evaluating the Inhibition Effect of Drugs on Cytochrome P450 Enzymes Based on Human-Induced Hepatocytes (hiHeps).一种基于人诱导肝细胞(hiHeps)评估药物对细胞色素P450酶抑制作用的新型系统。
Front Pharmacol. 2021 Oct 28;12:748658. doi: 10.3389/fphar.2021.748658. eCollection 2021.

本文引用的文献

1
Integration of Metabolomics With Pharmacodynamics to Elucidate the Anti-myocardial Ischemia Effects of Combination of Notoginseng Total Saponins and Safflower Total Flavonoids.代谢组学与药效学整合以阐明三七总皂苷与红花总黄酮配伍抗心肌缺血的作用机制
Front Pharmacol. 2018 Jun 25;9:667. doi: 10.3389/fphar.2018.00667. eCollection 2018.
2
Synergistic effects of rhubarb-gardenia herb pair in cholestatic rats at pharmacodynamic and pharmacokinetic levels.大黄-栀子药对在胆汁淤积大鼠体内药效学和药代动力学水平的协同作用。
J Ethnopharmacol. 2015 Dec 4;175:67-74. doi: 10.1016/j.jep.2015.09.012. Epub 2015 Sep 13.
3
Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals.
参与外源性和天然化学物质代谢的人类氧化还原酶和细胞色素P450酶的综述。
Chem Res Toxicol. 2015 Jan 20;28(1):38-42. doi: 10.1021/tx500444e. Epub 2014 Dec 19.
4
Characterization of the herb-derived components in rats following oral administration of Carthamus tinctorius extract by extracting diagnostic fragment ions (DFIs) in the MS(n) chromatograms.通过在质谱(n)色谱图中提取诊断性碎片离子(DFIs)来表征大鼠口服红花提取物后草药衍生成分。
Analyst. 2014 Dec 21;139(24):6474-85. doi: 10.1039/c4an01707b.
5
A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies.一种评估人细胞色素P450体外活性的联合方法:当前方法概述
J Pharm Biomed Anal. 2014 Dec;101:221-37. doi: 10.1016/j.jpba.2014.03.018. Epub 2014 Mar 28.
6
Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi).组合代谢显著影响口服服用三七(Sanqi)根提取物后人参皂苷在人体系统中的暴露量。
Drug Metab Dispos. 2013 Jul;41(7):1457-69. doi: 10.1124/dmd.113.051391. Epub 2013 May 6.
7
Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats.评价三七和红花的单体和组合提取物对大鼠心肌缺血的作用。
J Ethnopharmacol. 2013 Feb 13;145(3):722-7. doi: 10.1016/j.jep.2012.11.036. Epub 2012 Dec 10.
8
In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics.替格瑞洛潜在药物相互作用的体外评价:细胞色素 P450 反应表型、抑制、诱导和差异动力学。
Drug Metab Dispos. 2011 Apr;39(4):703-10. doi: 10.1124/dmd.110.037143. Epub 2010 Dec 22.
9
Component analysis and free radical-scavenging potential of Panax notoginseng and Carthamus tinctorius extracts.三七和红花提取物的成分分析及自由基清除能力。
Chem Biodivers. 2010 Feb;7(2):383-91. doi: 10.1002/cbdv.200800313.
10
In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies.通过细胞色素 P450 表型鉴定、抑制和诱导研究评估阿哌沙班的体外代谢药物相互作用潜力。
Drug Metab Dispos. 2010 Mar;38(3):448-58. doi: 10.1124/dmd.109.029694. Epub 2009 Nov 25.